v3 Template
T

Tempero Bio

Biopharmaceutical
Founded
--
Employees
--
Total Funding
$70.0M
Funding Rounds
1
Last Funding
2025-03-24

About Tempero Bio

Tempero Bio is a clinical-stage biopharmaceutical company focused on developing treatments for substance use disorders and related conditions. Their mission is to help people with addiction overcome treatment obstacles and move forward on the path to a healthier life by translating science into innovative medicines.

Products & Services

TMP-301:A potent, orally-available metabotropic glutamate receptor 5 (mGluR5) negative allosteric modulator (NAM) being investigated for the treatment of Substance Use Disorders, including Cocaine Use Disorder (CUD) and Alcohol Use Disorder (AUD), with potential applications for Opioid Use Disorder (OUD) and Polysubstance Use Disorder (PUD).

Specialties

Substance Use Disorder Treatments Metabotropic Glutamate Receptor 5 (mGluR5) Modulation Addiction Therapy Development

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Series B
T: -
FT: Series B 		A: 70000000
MR: -
FA: $70 Million
FAN: 70000000 		D: 2025-03-24
FD: 2025-03-24 		3 investors
Series B Latest
2025-03-24
$70.0M
3 investors (Pro only)

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

No team data available

Team information is not yet available for this company

Recent News

Tempero Bio Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biopharmaceutical

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro